Glen Eagle Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-18
| Closed | -$1.62K | – | 947 |
|
|
2020
Q1 | $1.62K | Hold |
18
| – | – | ﹤0.01% | 724 |
|
|
2019
Q4 | $1.95K | Hold |
18
| – | – | ﹤0.01% | 781 |
|
|
2019
Q3 | $1.76K | Hold |
18
| – | – | ﹤0.01% | 717 |
|
|
2019
Q2 | $2.36K | Hold |
18
| – | – | ﹤0.01% | 686 |
|
|
2019
Q1 | $2.43K | Hold |
18
| – | – | ﹤0.01% | 638 |
|
|
2018
Q4 | $1.75K | Hold |
18
| – | – | ﹤0.01% | 637 |
|
|
2018
Q3 | $2.5K | Hold |
18
| – | – | ﹤0.01% | 612 |
|
|
2018
Q2 | $2.24K | Hold |
18
| – | – | ﹤0.01% | 600 |
|
|
2018
Q1 | $2.01K | Buy |
+18
| New | +$2.01K | ﹤0.01% | 587 |
|
|
2017
Q4 | – | Sell |
-26
| Closed | -$3.65K | – | 682 |
|
|
2017
Q3 | $3.65K | Buy |
+26
| New | +$3.65K | ﹤0.01% | 546 |
|